Literature DB >> 30127565

Acquired Hemophilia A: Experience of a Tertiary Care Institute from North India.

Narender Kumar1, Sweta Rajpal1, Jasmina Ahluwalia1, Sunil Bose1, Varun Uppal1, Neelam Varma1, Pankaj Malhotra2, Subhash Varma2.   

Abstract

Acquired hemophilia A (AHA) is an uncommon bleeding disorder infrequently reported among Indians. The present retrospective data comprises eight cases of AHA over a period of 15 years. The mean age of patients was 59.7 years. The activated partial thromboplastin time was prolonged in all cases and the inhibitor screen showed the presence of inhibitors. Factor VIII: C assay was performed in 7 cases and all cases demonstrated low levels. Lupus anticoagulant was negative. Six patients were managed with steroids and symptomatic supportive care. These patients were followed up for a mean period of 3.5 years (range 1-5 years). Of these, there was one fatality prior to initiation of therapy and one patient continues to have inhibitors.

Entities:  

Keywords:  Acquired hemophilia; Activated partial thromboplastin time; Immunosuppression; Inhibitor assay; Inhibitor screen

Year:  2017        PMID: 30127565      PMCID: PMC6081324          DOI: 10.1007/s12288-017-0873-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  23 in total

Review 1.  Treatment of acquired hemophilia A.

Authors:  P W Collins
Journal:  J Thromb Haemost       Date:  2007-05       Impact factor: 5.824

2.  Consensus recommendations for the diagnosis and treatment of acquired hemophilia A.

Authors:  Peter Collins; Francesco Baudo; Angela Huth-Kühne; Jørgen Ingerslev; Craig M Kessler; Maria E Mingot Castellano; Midori Shima; Jean St-Louis; Hervé Lévesque
Journal:  BMC Res Notes       Date:  2010-06-07

Review 3.  Acquired haemophilia A: a 2013 update.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Thromb Haemost       Date:  2013-09-05       Impact factor: 5.249

Review 4.  Inhibitor treatment: state of the art.

Authors:  A Shapiro
Journal:  Semin Hematol       Date:  2001-10       Impact factor: 3.851

5.  Symptomatic Acquired Haemophilia Due to Circulating Antibodies Against Both Factor VIII and IX in a Non-haemophiliac Patient.

Authors:  Sharat Damodar; Prashantha Bhat; Sitalakshmi Balasubramaniam
Journal:  Indian J Hematol Blood Transfus       Date:  2013-05-24       Impact factor: 0.900

Review 6.  Management of acquired haemophilia A.

Authors:  P W Collins
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

7.  A population based, unselected, consecutive cohort of patients with acquired haemophilia A.

Authors:  Peter Collins; Nicola Macartney; Richard Davies; Steven Lees; John Giddings; Ray Majer
Journal:  Br J Haematol       Date:  2004-01       Impact factor: 6.998

Review 8.  Advances in the understanding of acquired haemophilia A: implications for clinical practice.

Authors:  Peter W Collins; Charles L Percy
Journal:  Br J Haematol       Date:  2009-10-07       Impact factor: 6.998

9.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.

Authors:  Angela Huth-Kühne; Francesco Baudo; Peter Collins; Jørgen Ingerslev; Craig M Kessler; Hervé Lévesque; Maria Eva Mingot Castellano; Midori Shima; Jean St-Louis
Journal:  Haematologica       Date:  2009-04       Impact factor: 9.941

10.  Acquired factor VIII inhibitor syndrome: A rare cause of hematuria.

Authors:  Muthuvel Seral Kannan; Thallur Ramakrishnan Raj Kumar; Srinivasan Subramanian
Journal:  Indian J Urol       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.